Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas FC Geyer, A Li, AD Papanastasiou, A Smith, P Selenica, KA Burke, ... Nature communications 9 (1), 1816, 2018 | 132 | 2018 |
Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors F Pareja, AH Brandes, T Basili, P Selenica, FC Geyer, D Fan, ... Nature Communications 9 (1), 3533, 2018 | 108 | 2018 |
Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations … JR Lozada, T Basili, F Pareja, B Alemar, ADC Paula, R Gularte‐Merida, ... Histopathology 73 (2), 339-344, 2018 | 57 | 2018 |
Homologous recombination DNA repair defects in PALB2-associated breast cancers A Li, FC Geyer, P Blecua, JY Lee, P Selenica, DN Brown, F Pareja, ... NPJ breast cancer 5 (1), 23, 2019 | 53 | 2019 |
Histologic classification and molecular signature of polymorphous adenocarcinoma (PAC) and cribriform adenocarcinoma of salivary gland (CASG): an international interobserver study B Xu, AL Barbieri, JA Bishop, SI Chiosea, S Dogan, S Di Palma, ... The American journal of surgical pathology 44 (4), 545-552, 2020 | 47 | 2020 |
Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity F Pareja, EM da Silva, D Frosina, FC Geyer, JR Lozada, T Basili, ... Modern Pathology 33 (6), 1056-1064, 2020 | 38 | 2020 |
Histologic spectrum of polymorphous adenocarcinoma of the salivary gland harbor genetic alterations affecting PRKD genes APM Sebastiao, B Xu, JR Lozada, F Pareja, FC Geyer, ADC Paula, ... Modern Pathology 33 (1), 65-73, 2020 | 34 | 2020 |
Myxoid fibroadenomas differ from conventional fibroadenomas: a hypothesis‐generating study JR Lozada, KA Burke, A Maguire, F Pareja, RS Lim, J Kim, ... Histopathology 71 (4), 626-634, 2017 | 31 | 2017 |
Massively parallel sequencing analysis of benign melanocytic naevi JR Lozada, FC Geyer, P Selenica, D Brown, B Alemar, T Merghoub, ... Histopathology 75 (1), 29-38, 2019 | 15 | 2019 |
ST3GAL1 and βII-spectrin pathways control CAR T cell migration to target tumors Y Hong, BL Walling, HR Kim, WS Serratelli, JR Lozada, CJ Sailer, ... Nature immunology 24 (6), 1007-1019, 2023 | 12 | 2023 |
Whole‐exome analysis of metaplastic breast carcinomas with extensive osseous differentiation F Beca, APM Sebastiao, F Pareja, K Dessources, JR Lozada, F Geyer, ... Histopathology 77 (2), 321-326, 2020 | 7 | 2020 |
Abstract PD4-13: Estrogen receptor-negative breast adenomyoepitheliomas are driven by co-occurring HRAS hotspot and PI3K pathway gene mutations: A genetic … FC Geyer, A Li, AD Papanastasiou, A Smith, P Selenica, KA Burke, ... Cancer Research 78 (4_Supplement), PD4-13-PD4-13, 2018 | 3 | 2018 |
Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer HE Bergom, LA Sena, A Day, B Miller, CD Miller, JR Lozada, N Zorko, ... npj Genomic Medicine 9 (1), 7, 2024 | 1 | 2024 |
NK Cells from Human Cytomegalovirus–Seropositive Individuals Have a Distinct Metabolic Profile That Correlates with Elevated mTOR Signaling JR Lozada, B Zhang, JS Miller, F Cichocki The Journal of Immunology 211 (4), 539-550, 2023 | 1 | 2023 |
Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes J Hwang, X Shi, A Elliott, TE Arnoff, J McGrath, J Xiu, P Walker, ... Clinical Cancer Research 29 (14), 2702-2713, 2023 | 1 | 2023 |
Pan-cancer analysis of natural killer (NK) cell infiltration in human malignancies: Molecular features and clinical implications. N Zorko, J Hwang, JR Lozada, H Seifert, A Elliott, M Radovich, ... Journal of Clinical Oncology 41 (16_suppl), 2563-2563, 2023 | 1 | 2023 |
ALAN is a computational approach that interprets genomic findings in the context of tumor ecosystems HE Bergom, A Shabaneh, A Day, A Ali, E Boytim, S Tape, JR Lozada, ... Communications biology 6 (1), 417, 2023 | 1 | 2023 |
Molecular correlates of Delta-like-ligand 3 (DLL3) expression in neuroendocrine neoplasms (NENs) J Hwang, J McGrath, JR Lozada, P Brodskiy, J Xiu, S Wei, EI Heath, ... J. Clin. Oncol 40, 4127, 2022 | 1 | 2022 |
Massively parallel sequencing analysis of myxoid fibroadenomas reveals a genomic landscape distinct from that of conventional fibroadenomas JR Lozada, F Pareja, KA Burke, A Maguire, M Murray, E Brogi, B Weigelt, ... LABORATORY INVESTIGATION 97, 57A-57A, 2017 | 1 | 2017 |
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes NA Zorko, A Makovec, A Elliott, S Kellen, JR Lozada, AT Arafa, M Felices, ... Prostate Cancer and Prostatic Diseases, 1-9, 2024 | | 2024 |